Agenda Archive

Case Study: Cutting edge technology – using AI in rare diseases

Sharing insights on how to use AI to bring drugs to rare disease patients
Running through step by step processes including pre IND, FDA work, organising and conducting trial
Discussing challenges, successes and real-world experience

Starting on the right foot: Considerations for training and validation of AI-driven medical devices
Clinical performance: Steps to efficient clinical validation based on case example
Market entry: Hurdles with Notified Body review and approval
What happens next: Iterating in the post-market setting

Reviewing model code and architecture using XAI (explainable AI) techniques to interpret outputs and algorithms
Mitigating and re-testing strategies to find the right solution for your value chain
How can we generate simplicity with AI and agility with current infrastructures?

How do we perceive the current state of AI and automation adoption in Asia?
Exploring communication techniques to maintain a balanced level of integrated AI strategies and initiatives
Productionising GenAI – is it giving the right data and outputs?

Moving from automation to strategic intelligence: how AI will shape decision-making, risk management, and new business models
Preparing for the next investment cycle: what C-level leaders need to prioritise to stay ahead
The rise of real-time, agentic AI: transforming customer experience and operational agility
Building future-ready data foundations and compliance frameworks across diverse APAC markets
How Asia’s unique demographics, digital maturity, and regulatory momentum are positioning the region to set global standards for responsible AI in finance